missing translation for 'onlineSavingsMsg'
Learn More

LHX1 Monoclonal Antibody (OTI2G3), TrueMAB™, OriGene

Mouse Monoclonal Antibody

Encompass_Preferred

2832.96 NOK - 6331.68 NOK

Specifications

Antigen LHX1
Clone OTI2G3
Concentration 0.83 mg/mL
Classification Monoclonal
Conjugate Unconjugated
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
17521852
Encompass_Preferred
View Documents
Origene Technologies
TA504534S
30 μL
2832.96 NOK
30µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
17501852
Encompass_Preferred
View Documents
Origene Technologies
TA504534
100 μL
6331.68 NOK
100µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

LHX1 Monoclonal antibody specifically detects LHX1 in Human samples. It is validated for Flow Cytometry, Immunocytochemistry, Western Blot
Specifications

Specifications

LHX1
0.83 mg/mL
Unconjugated
Mouse
Human
3975
Primary
OTI2G3
Monoclonal
Liquid
RUO
P48742
IgG1
-20° C, Avoid Freeze/Thaw Cycles
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title
LHX1 Monoclonal Antibody (OTI2G3), TrueMAB™, OriGene

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.